BGNE - BeiGene Quarterly EPS earnings growth

BeiGene, Ltd. - graphic logo of issuer BGNE

BeiGene, Ltd. (BGNE) relies on a hybrid model, combining its own laboratories with the utilization of external CDMOs and CROs. The quarterly EPS trend helps assess the real pace of business recovery, where 201.40 represents the current metric. Prospects are linked to the expansion of the Western warehouse network and the global market penetration of Chinese innovations through affordable oncology therapy.

beigene.com (BGNE) - Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/17/2026

Summary analytical data breakdowns for BeiGene, Ltd. (BGNE)

- market value and analyst target forecast:
Fundamental company analysis:beigene.com - BGNE
Flagship merchandise of BeiGene Ltd

This metric serves as a filter to separate fundamentally resilient assets from overvalued companies during portfolio stress testing. It measures the percentage change in net income per share per quarter, reflecting the dynamics of actual earnings; by analyzing the history of quarterly earnings per share changes, one can see how the global expansion of Brukinsa and regulatory approvals are transforming BeiGene, Ltd. (BGNE) from a biotech startup into a profitable behemoth.

Analysis of competing companies

ONC: Quarterly EPS earnings growth|Halozyme Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (Revolution Medicines Inc) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Group AAPG|Quarterly EPS earnings growth CGON|Quarterly EPS earnings growth UroGen Pharma Ltd (URGN)|Quarterly EPS earnings growth BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Earnings per share growth in annualized terms for the last twelve months|Erasca Oncology - Quarterly EPS earnings growth|DCTH: Year-over-year earnings per share growth for the last twelve months|YMAB: Quarterly EPS earnings growth|Aura Bio (AURA) - Quarterly EPS earnings growth|CADL (Candel Therapeutics Inc.) - Quarterly EPS earnings growth|ARAY: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SLS (SELLAS Life Sciences Group, Inc.)|Year-over-year earnings per share growth rate for the last twelve months ACTU|Citius Oncology - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months HURA|TARA: Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Fate Pharma|Aadi Bioscience Inc (WHWK) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months TScan (TCRX)|Year-over-year net earnings per share growth for the last 12 months CSBR|xbiotech.com (XBIT) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months cel-sci.com (CVM)|OSTX - Earnings per share growth in annualized terms for the last twelve months|Radiopharm Theranostics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ARTV|ANL - Year-over-year earnings per share growth for the last twelve months|VERU - Quarterly EPS earnings growth|Tempest Therapeutics, Inc. (TPST) - Year-over-year earnings per share growth for the last twelve months|XLO: Year-over-year earnings per share growth rate for the last twelve months|RENB (Renovaro Biosciences) - Quarterly EPS earnings growth|MURA: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KAPA (Kairos Pharma Ltd)|Year-over-year earnings per share growth rate for the last twelve months OKUR|CytoMed Therapeutics Limited - Year-over-year net earnings per share growth for the last 12 months|CRIS: Year-over-year earnings per share growth for the last 12 months|APLM - Year-over-year earnings per share growth for the last twelve months|THAR - Quarterly EPS earnings growth|ADVB: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months SBFM|Quarterly EPS earnings growth XBIO|Year-over-year net earnings per share growth for the last 12 months Salarius Pharmaceuticals SLRX|Quarterly EPS earnings growth PPBT (Purple Biotech Ltd)|AONC - Year-over-year net earnings per share growth for the last 12 months|CKPT - Year-over-year earnings per share growth for the last twelve months|Elevation Oncology (ELEV) - Year-over-year net earnings per share growth for the last 12 months|ICAD: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Ikena Oncology Inc.|NTBL (Notable Labs Ltd) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Viracta Therapeutics (VIRX)|Year-over-year earnings per share growth for the last twelve months MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth AAPGV (Ascentage)